Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Vogel

Showing results (281-290 of 294) with videos related to

Pageof 30
Sort By:
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 17, 2025
Patient-, care partner-, and clinician-proposed solutions to address the time toxicity of cancer careWhitney V Johnson, Sai S Valisekka, Obafemi O Ogunleye, et al.
JCO Oncology Practice|September 22, 2023
Health Care Contact Days Experienced by Decedents With Advanced GI CancerVishal R Patel, Vidhyalakshmi Ramesh, Alexander K Tsai, et al.
JAMA Network Open|November 27, 2024
Patient, Caregiver, and Clinician Perspectives on the Time Burdens of Cancer CareArjun Gupta, Whitney V Johnson, Nicole L Henderson, et al.
European Journal of Dental Education : Official Journal of the Association for Dental Education in Europe|October 23, 2002
1.3 Development of professional competencesAlphons Plasschaert, Marcia Boyd, Sandra Andrieu, et al.
Biorxiv : the Preprint Server for Biology|February 3, 2025
Tobacco smoke carcinogens exacerbate APOBEC mutagenesis and carcinogenesisCameron Durfee, Erik N Bergstrom, Marcos Díaz-Gay, et al.
International Journal of Molecular Sciences|June 10, 2023
DNA Deamination Is Required for Human APOBEC3A-Driven Hepatocellular Carcinoma In VivoJordan A Naumann, Prokopios P Argyris, Michael A Carpenter, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2023
Human APOBEC3B promotes tumor heterogeneity <i>in vivo</i> including signature mutations and metastasesCameron Durfee, Nuri Alpay Temiz, Rena Levin-Klein, et al.
Cell Reports. Medicine|October 5, 2023
Human APOBEC3B promotes tumor development in vivo including signature mutations and metastasesCameron Durfee, Nuri Alpay Temiz, Rena Levin-Klein, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 16, 2020
The DNA Cytosine Deaminase APOBEC3B is a Molecular Determinant of Platinum Responsiveness in Clear Cell Ovarian CancerArtur A Serebrenik, Prokopios P Argyris, Matthew C Jarvis, et al.
The Journal of Experimental Medicine|September 2, 2020
APOBEC3A catalyzes mutation and drives carcinogenesis in vivoEmily K Law, Rena Levin-Klein, Matthew C Jarvis, et al.
Pageof 30

Showing results (281-290 of 294) with videos related to

Sort By:
Pageof 30
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 17, 2025
Patient-, care partner-, and clinician-proposed solutions to address the time toxicity of cancer careWhitney V Johnson, Sai S Valisekka, Obafemi O Ogunleye, et al.
JCO Oncology Practice|September 22, 2023
Health Care Contact Days Experienced by Decedents With Advanced GI CancerVishal R Patel, Vidhyalakshmi Ramesh, Alexander K Tsai, et al.
JAMA Network Open|November 27, 2024
Patient, Caregiver, and Clinician Perspectives on the Time Burdens of Cancer CareArjun Gupta, Whitney V Johnson, Nicole L Henderson, et al.
European Journal of Dental Education : Official Journal of the Association for Dental Education in Europe|October 23, 2002
1.3 Development of professional competencesAlphons Plasschaert, Marcia Boyd, Sandra Andrieu, et al.
Biorxiv : the Preprint Server for Biology|February 3, 2025
Tobacco smoke carcinogens exacerbate APOBEC mutagenesis and carcinogenesisCameron Durfee, Erik N Bergstrom, Marcos Díaz-Gay, et al.
International Journal of Molecular Sciences|June 10, 2023
DNA Deamination Is Required for Human APOBEC3A-Driven Hepatocellular Carcinoma In VivoJordan A Naumann, Prokopios P Argyris, Michael A Carpenter, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2023
Human APOBEC3B promotes tumor heterogeneity <i>in vivo</i> including signature mutations and metastasesCameron Durfee, Nuri Alpay Temiz, Rena Levin-Klein, et al.
Cell Reports. Medicine|October 5, 2023
Human APOBEC3B promotes tumor development in vivo including signature mutations and metastasesCameron Durfee, Nuri Alpay Temiz, Rena Levin-Klein, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 16, 2020
The DNA Cytosine Deaminase APOBEC3B is a Molecular Determinant of Platinum Responsiveness in Clear Cell Ovarian CancerArtur A Serebrenik, Prokopios P Argyris, Matthew C Jarvis, et al.
The Journal of Experimental Medicine|September 2, 2020
APOBEC3A catalyzes mutation and drives carcinogenesis in vivoEmily K Law, Rena Levin-Klein, Matthew C Jarvis, et al.
Pageof 30